• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.在含有人类1号染色体的小鼠A9细胞上表达的人类补体调节蛋白。
Immunology. 1991 Dec;74(4):719-24.
2
Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.补体膜辅因子蛋白(MCP)的定量分析。MCP在人白血病细胞系上高表达,在细胞分化过程中表达下调。
J Immunol. 1990 Jul 1;145(1):238-45.
3
Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.补体调节蛋白CD21、CD55和CD59在伯基特淋巴瘤细胞系中的表达:它们在对人血清介导的细胞溶解敏感性中的作用。
Eur J Immunol. 1992 Jul;22(7):1871-6. doi: 10.1002/eji.1830220729.
4
Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.补体调节蛋白在人类胚胎、野生型和转基因猪神经组织中低水平表达。
Xenotransplantation. 2004 Jan;11(1):60-71. doi: 10.1111/j.1399-3089.2004.00084.x.
5
Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.一种杂交补体调节蛋白——中国仓鼠卵巢细胞膜辅因子蛋白衰变加速因子的表达。其调节作用与衰变加速因子和膜辅因子蛋白调节作用的比较。
J Immunol. 1994 Apr 1;152(7):3436-44.
6
Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAE hybrid, on complement-mediated swine endothelial cell lysis.转染的补体调节蛋白、膜辅助蛋白(MCP)、衰变加速因子(DAF)以及MCP/DAF杂合体对补体介导的猪内皮细胞裂解的影响。
Transplantation. 1994 Oct 15;58(7):834-40.
7
Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.细胞因子介导的人血管内皮细胞上补体调节蛋白CD46(膜辅蛋白)、CD55(衰变加速因子)和CD59表面表达的调控
Lymphokine Cytokine Res. 1993 Jun;12(3):167-72.
8
Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).人类胎盘发育过程中母胎界面的补体调节蛋白:CD59与膜辅因子蛋白(CD46)和衰变加速因子(CD55)的分布比较
Eur J Immunol. 1992 Jun;22(6):1579-85. doi: 10.1002/eji.1830220635.
9
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.小鼠和人类细胞中重组补体受体2(CR2/CD21)的表位表达及功能谱分析。
J Immunol. 1989 Aug 1;143(3):923-30.
10
Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.交联CD21/CD35或CD19可增加小鼠脾脏B细胞上B7-1和B7-2的表达。
J Immunol. 1998 Feb 15;160(4):1565-72.

引用本文的文献

1
Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects.在正常受试者的血浆、眼泪和精液中存在膜辅因子蛋白(CD46,MCP)的可溶性形式。
Clin Exp Immunol. 1992 Sep;89(3):490-4. doi: 10.1111/j.1365-2249.1992.tb06986.x.

本文引用的文献

1
Complement C3 receptors: structure and function.补体C3受体:结构与功能
Mol Immunol. 1984 Dec;21(12):1191-9. doi: 10.1016/0161-5890(84)90009-9.
2
The alternative pathway of complement.补体替代途径
Springer Semin Immunopathol. 1984;7(2-3):163-92. doi: 10.1007/BF01893019.
3
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.衰变加速因子(DAF)整合到细胞膜后对细胞表面补体激活的抑制作用。
J Exp Med. 1984 Nov 1;160(5):1558-78. doi: 10.1084/jem.160.5.1558.
4
Surface-dependent modulation by H of C5 cleavage by the cell-bound alternative pathway C5 convertase of human complement.人补体的细胞结合替代途径C5转化酶对C5裂解的表面依赖性H调节作用
J Immunol. 1983 Jun;130(6):2821-4.
5
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).C3b/C4b受体(CR1)多态性变体的纯化与功能分析及其与H、C4b结合蛋白(C4bp)和衰变加速因子(DAF)的比较。
J Immunol. 1985 Oct;135(4):2661-7.
6
Membrane complement receptors specific for bound fragments of C3.
Adv Immunol. 1985;37:217-67. doi: 10.1016/s0065-2776(08)60341-7.
7
Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).小鼠补体激活的第三和第四成分(C3b和C4b)的调节蛋白。II. 1型补体受体(CR1)的鉴定与特性
J Immunol. 1985 Apr;134(4):2564-70.
8
The mechanism of discordant xenograft rejection.异种移植排斥反应不一致的机制。
Transplantation. 1988 Dec;46(6):825-30. doi: 10.1097/00007890-198812000-00007.
9
CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.CR2是一种补体激活剂,也是Raji细胞在替代途径激活过程中C3的共价结合位点。
J Immunol. 1988 Mar 15;140(6):1923-9.
10
The regulators of complement activation (RCA) gene cluster.补体激活调节因子(RCA)基因簇
Adv Immunol. 1989;45:381-416. doi: 10.1016/s0065-2776(08)60697-5.

在含有人类1号染色体的小鼠A9细胞上表达的人类补体调节蛋白。

Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.

作者信息

Seya T, Okada M, Hara T, Matsumoto M, Miyagawa S, Oshimura M

机构信息

Department of Immunology, Center for Adult Diseases Osaka, Higashinari-ku, Japan.

出版信息

Immunology. 1991 Dec;74(4):719-24.

PMID:1723716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1384786/
Abstract

The structural genes of human complement regulatory proteins are clustered on chromosome 1 at position q3.2. Human chromosome 1 was transferred into a mouse fibroblast cell line, A9 [designated as A9(neo-1)], and the surface expression of its gene products participating in complement regulation, namely C3b/C4b receptor (CR1, CD35), decay-accelerating factor (DAF, CD55), membrane co-factor protein (MCP, CD46) and C3d/EB virus receptor (CR2, CD21), were assessed using respective monoclonal antibodies by flow cytometry. CR1 became positive within 7 days of culture. MCP appeared in a small population of cells by Day 3 and, together with DAF, began to increase on Day 7. CR2 appeared on Day 14. The order of the expression was CR1 greater than DAF = MCP greater than CR2. On Day 42, however, all became negative except for MCP, which was markedly diminished. These human regulatory proteins were specifically associated with the presence of human chromosome 1, since none of them were expressed on human chromosome 12-transferred A9 cells [A9(neo-12)]. Intact A9 and A9(neo-12) cells activated human complement via the alternative pathway. The activation of this pathway was suppressed in the A9(neo-1) cells that expressed CR1, DAF and MCP. Slight protective activity was still observed in the 42-day cultured A9(neo-1) cells expressing only trace MCP. These results suggest that human complement regulators, expressed via the transferred human chromosome 1, can protect heterologous cells from complement, overcoming their ability to activate the human alternative pathway.

摘要

人类补体调节蛋白的结构基因聚集在1号染色体的q3.2位置。将人类1号染色体转入小鼠成纤维细胞系A9 [命名为A9(neo-1)],通过流式细胞术使用各自的单克隆抗体评估参与补体调节的基因产物在其表面的表达,即C3b/C4b受体(CR1,CD35)、衰变加速因子(DAF,CD55)、膜辅因子蛋白(MCP,CD46)和C3d/EB病毒受体(CR2,CD21)。CR1在培养7天内呈阳性。MCP在第3天出现在一小部分细胞中,并与DAF一起在第7天开始增加。CR2在第14天出现。表达顺序为CR1大于DAF = MCP大于CR2。然而,在第42天,除了明显减少的MCP外,所有其他蛋白均变为阴性。这些人类调节蛋白与人类1号染色体的存在特异性相关,因为它们在转入人类12号染色体的A9细胞[A9(neo-12)]上均未表达。完整的A9和A9(neo-